Granules pioneered the concept of commercializing PFIs or Pre formulation Ingredients, a conception for large-volume drug molecules within the pharmaceutical production.

We entered into this business segment in the early 90s, following an insight that most finished dosage manufacturers were not efficiently producing PFIs. Manufacturers were granulating but could not derive operational efficiencies. They focused on dozens of products or only created large-volume products in limited quantities, each batch of which was processed & tested individually. 
Consequently, it increased the overall cost to the manufacturers and in turn the customers, which finally resulted in an increased cost of product to the end consumer. This also pulled down the overall return from the manufacturers’ ‘investments,’ especially because PFI manufacturing accounts for 80% of the total cost of a finished dosage.

Granules India offers PFIs that are meant to be taken from ‘drum to hopper’ 
by our customers. The pre-formulation ingredients are taken directly from the drums to a hopper, where they are directly compressed into tablets.